Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Immunovant, Inc.
IMVT · Transcripts
website
315
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advanci...
Price
33.93
Market Cap
7.19 B
Float
84.83 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about IMVT
Immunovant, Inc.
IMVT · Transcripts
84.83 M
Float
33.93
Price
7.19 B
Market Cap
2024
AI
Type
Title
Quarter
Created Date
2023
AI
Type
Title
Quarter
Created Date
2022
AI
Type
Title
Quarter
Created Date
2021
AI
Type
Title
Quarter
Created Date
